🧾 What This Document Is

This is a Definitive Proxy Statement (DEF 14A) for Community Health Systems, Inc. (CYH). It’s sent to shareholders ahead of the 2026 Annual Meeting to give them info and ask for their votes on key proposals. Think of it as the company’s "meeting agenda + report card" for shareholders.

🏢 What The Company Does

👉 In simple terms, Community Health Systems owns and operates general acute care hospitals and outpatient facilities across the U.S. They’re one of the largest for-profit hospital chains in the country. Their business is running healthcare systems, managing hospitals, and expanding access points like urgent care centers and surgery centers.

💰 Financial Highlights (2025 vs. 2024)

Despite a "challenging operating environment," the company made progress:

• Net Operating Revenues: $12.485 billion (down 1.2% from $12.634B), but same-store revenues grew 4.6%.
• Net Income: $509 million profit (vs. a $516 million loss in 2024) — a 198.6% swing.
• Adjusted EBITDA: $1.526 billion (slightly down from $1.540B), holding steady at 12.2% of revenue.
• Cash Flow from Operations: $543 million (up 13.1% from $480M).
• Earnings per Share (EPS): $3.77 (vs. -$3.90 in 2024).
• Stock Price: Closed at $3.12 on Dec 31, 2025 (up 4.3% from $2.99).

👉 Why it matters: The company flipped from a big loss to a profit, grew same-store revenue, and improved cash flow — signs of stabilization after a tough period. High debt remains a challenge.

🚀 Key Moves in 2025: Debt Overhaul

The company aggressively refinanced its debt to lower near-term risks and extend maturities:

• May 2025: Bought back ~$584M of its 6.875% 2028 notes via tender offer.
• May 2025: Issued $700M of 10.75% 2033 secured notes to retire $700M of 8% 2027 notes.
• August 2025: Issued $1.79B of 9.75% 2034 secured notes to redeem ~$1.743B of 5.625% 2027 notes.
• December 2025: Redeemed remaining $14M of 5.625% 2027 notes and 10% ($223M) of its 10.875% 2032 notes at a 103% premium.

👉 Why it matters: They swapped near-term debt maturities (2027/2028) for longer-term debt (2033/2034) — but at much higher interest rates (up to 10.75%). This reduces immediate default risk but increases long-term interest costs.

📦 What Shareholders Are Voting On

Three proposals, all recommended FOR by the Board:

1. Election of 14 Directors: Includes the new CEO (Kevin Hammons), the Chairman (Wayne Smith), and experts in healthcare, finance, cybersecurity, and academia.
2. Advisory Vote on Executive Compensation ("Say-on-Pay"): Shareholders get a non-binding vote on top executives’ pay. Last year, 97% approved.
3. Ratify Deloitte & Touche LLP as Auditor for 2026.

👥 Board & Governance Highlights

• 14 Director Nominees: 6 are diverse by gender or ethnicity.
• Board Independence: 12 of 14 nominees are independent.
• Leadership Structure: Board Chair (Wayne Smith) and CEO (Kevin Hammons) are separate roles — a commitment kept from a 2024 legal settlement.
• Meetings: The Board and committees met frequently in 2025 (e.g., non-management directors met 12 times in executive session).
• Stockholder Engagement: In 2025, the company interacted with investors holding >50% of shares.

💸 Executive Compensation (CEO Transition)

• CEO Change: Tim Hingtgen retired Sept 30, 2025. Kevin Hammons (former CFO) became CEO Oct 1, 2025.
• Pay Philosophy: Heavy focus on "at-risk" pay (annual bonuses + long-term equity). For 2025:
  • CEO (Hingtgen): 81% of target pay was "at-risk" — but he forfeited 2025 bonuses/equity due to retirement.
  • Other Executives: Avg. 61% of target pay was "at-risk."
• 2025 Bonus Outcome: Hammons received 119% of target for 2025 performance (vs. 108% for Hingtgen in 2024).
• Long-Term Incentives: 75% of equity awards are performance-based (options/restricted stock), tying pay to stock price and financial goals.

🔮 What’s Next

• Annual Meeting: May 12, 2026, in Franklin, TN.
• Strategy Focus: Expand access points (e.g., urgent care, surgery centers), manage costs (labor/supplies), improve quality metrics, and continue reducing debt.
• 2026 Outlook: Building on 2025 momentum — same-store growth, ERP system maturity, and capital structure improvements.

⚖️ Big Picture: Strengths & Risks

👍 Strengths:

• Same-store revenue & volume growth.
• Successful debt restructuring extends maturities.
• New CEO (Hammons) brings deep internal experience.
• Strong board independence and governance practices.

⚠️ Risks:

• High-interest debt (up to 10.75%) burdens future earnings.
• Healthcare industry faces labor cost pressures, regulatory complexity.
• Stock price is volatile and low (~$3).
• 2025 revenue still declined overall (-1.2%).

🧠 The Analogy

Imagine CYH is a homeowner with a mortgage coming due soon, panicking about rising rates. Instead of defaulting, they refinance into a much bigger loan with a higher rate but a longer payoff timeline — buying time to renovate (expand services) and increase their home’s value (grow revenue), but now their monthly interest payments are heavier, so they can’t afford missteps.

📇 Key Contacts & People

• Kevin J. Hammons: CEO (since Oct 1, 2025), Director since 2025.
• Wayne T. Smith: Chairman of the Board (since 1997).
• John A. Clerico: Independent Lead Director (since 2003).
• Investor Relations Contact:
  📞 (615) 465-7000
  ✉️ [email protected]
• Corporate Secretary:
  Community Health Systems, Inc.
  4000 Meridian Boulevard, Franklin, TN 37067
  📞 (615) 465-7000
• Independent Auditor: Deloitte & Touche LLP (ratification requested for 2026).
• Proxy Solicitor: Georgeson Inc. (~$21,000 fee + expenses).

🧩 Final Takeaway

CYH made real progress in 2025 — flipping to profit, growing same-store revenue, and overhauling its debt wall. But with new higher-interest debt and an unchanged low stock price, the new CEO must execute on operations and growth to prove the turnaround is sustainable. Shareholders are being asked to endorse the board and the pay-for-performance culture.